Animal models of medication- related osteonecrosis of the jaw

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Bisphosphonates have been extensively studied with hundreds of studies describing how they affect various skeletal parameters using animal models. Despite this extensive body of literature, when the clinical description of osteonecrosis of the jaw emerged in 2003/2004, the relative paucity of data describing how bisphosphonates affect the maxillofacial skeletal became clear. Over the past 10 years, there have been several dozen publications showing various aspects of ONJ in mice, rats, dogs, and swine treated with bisphosphonates. Recent work has extended these fi ndings to treatment with RANK-L inhibitors. The establishment of these models will be essential in propelling the fi eld forward to understand the underlying pathophysiology of ONJ and ultimately fi nding a way to prevent or cure this debilitating condition.

Original languageEnglish (US)
Title of host publicationMedication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents
PublisherSpringer Berlin Heidelberg
Pages155-167
Number of pages13
ISBN (Print)9783662437339, 9783662437322
DOIs
StatePublished - Jan 1 2015

Fingerprint

Osteonecrosis
Diphosphonates
Jaw
Animal Models
Publications
Swine
Dogs

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Allen, M. (2015). Animal models of medication- related osteonecrosis of the jaw. In Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents (pp. 155-167). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-43733-9_15

Animal models of medication- related osteonecrosis of the jaw. / Allen, Matthew.

Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents. Springer Berlin Heidelberg, 2015. p. 155-167.

Research output: Chapter in Book/Report/Conference proceedingChapter

Allen, M 2015, Animal models of medication- related osteonecrosis of the jaw. in Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents. Springer Berlin Heidelberg, pp. 155-167. https://doi.org/10.1007/978-3-662-43733-9_15
Allen M. Animal models of medication- related osteonecrosis of the jaw. In Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents. Springer Berlin Heidelberg. 2015. p. 155-167 https://doi.org/10.1007/978-3-662-43733-9_15
Allen, Matthew. / Animal models of medication- related osteonecrosis of the jaw. Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents. Springer Berlin Heidelberg, 2015. pp. 155-167
@inbook{14106a9c463140c0a226bac265373103,
title = "Animal models of medication- related osteonecrosis of the jaw",
abstract = "Bisphosphonates have been extensively studied with hundreds of studies describing how they affect various skeletal parameters using animal models. Despite this extensive body of literature, when the clinical description of osteonecrosis of the jaw emerged in 2003/2004, the relative paucity of data describing how bisphosphonates affect the maxillofacial skeletal became clear. Over the past 10 years, there have been several dozen publications showing various aspects of ONJ in mice, rats, dogs, and swine treated with bisphosphonates. Recent work has extended these fi ndings to treatment with RANK-L inhibitors. The establishment of these models will be essential in propelling the fi eld forward to understand the underlying pathophysiology of ONJ and ultimately fi nding a way to prevent or cure this debilitating condition.",
author = "Matthew Allen",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-662-43733-9_15",
language = "English (US)",
isbn = "9783662437339",
pages = "155--167",
booktitle = "Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Animal models of medication- related osteonecrosis of the jaw

AU - Allen, Matthew

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Bisphosphonates have been extensively studied with hundreds of studies describing how they affect various skeletal parameters using animal models. Despite this extensive body of literature, when the clinical description of osteonecrosis of the jaw emerged in 2003/2004, the relative paucity of data describing how bisphosphonates affect the maxillofacial skeletal became clear. Over the past 10 years, there have been several dozen publications showing various aspects of ONJ in mice, rats, dogs, and swine treated with bisphosphonates. Recent work has extended these fi ndings to treatment with RANK-L inhibitors. The establishment of these models will be essential in propelling the fi eld forward to understand the underlying pathophysiology of ONJ and ultimately fi nding a way to prevent or cure this debilitating condition.

AB - Bisphosphonates have been extensively studied with hundreds of studies describing how they affect various skeletal parameters using animal models. Despite this extensive body of literature, when the clinical description of osteonecrosis of the jaw emerged in 2003/2004, the relative paucity of data describing how bisphosphonates affect the maxillofacial skeletal became clear. Over the past 10 years, there have been several dozen publications showing various aspects of ONJ in mice, rats, dogs, and swine treated with bisphosphonates. Recent work has extended these fi ndings to treatment with RANK-L inhibitors. The establishment of these models will be essential in propelling the fi eld forward to understand the underlying pathophysiology of ONJ and ultimately fi nding a way to prevent or cure this debilitating condition.

UR - http://www.scopus.com/inward/record.url?scp=84956841605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956841605&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43733-9_15

DO - 10.1007/978-3-662-43733-9_15

M3 - Chapter

AN - SCOPUS:84956841605

SN - 9783662437339

SN - 9783662437322

SP - 155

EP - 167

BT - Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents

PB - Springer Berlin Heidelberg

ER -